Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Biomaterials. 2010 Feb 2;31(12):3185–3200. doi: 10.1016/j.biomaterials.2010.01.041

Table 1. Primary antibodies used in this study.

Primary Antibodies Dilutions Source Cell Target
BMSCs characterization markers
CD11b 1:50 BD Pharmingen Leukocytes
CD31 1:10 Abcam Endothelial
CD34 1:50 Santa Cruz Biotechnology Endothelial
CD44 1:10 Gene Tex, Inc Leukocytes
CD45 1:50 BD Pharmingen Hematopoietic
CD73 1:50 BD Pharmingen BMSCs
CD90 1:50 BD Pharmingen BMSCs
CD106 1:50 BD Pharmingen Endothelial
OX43 1:10 Gene Tex, Inc Endothelial
Cardiac myocyte differentiation markers
Sarcomere myosin (MF20) 1:100 DSHB Cardiomyocyte
Cardiac myosin heavy chain (α/β MHC) 1:100 Abcam Cardiomyocyte
Cardiac troponin I (cTnI) 1:100 Santa Cruz Biotechnology Cardiomyocyte
Cardiac α-actinin 1:100 Santa Cruz Biotechnology Cardiomyocyte
Connexin 43 (Cx43) 1:100 Santa Cruz Biotechnology Cardiomyocyte
N Cadherin 1:100 Santa Cruz Biotechnology Cardiomyocyte
Desmin 1:100 Abcam Cardiomyocyte
GATA4 1:100 Santa Cruz Biotechnology Cardiomyocyte
ANP 1:100 Santa Cruz Biotechnology Cardiomyocyte
BNP 1:100 Santa Cruz Biotechnology Cardiomyocyte